Key facts
- It has raised $2.8M; the latest was Early Stage VC in Jun 2025.
- Notable investors include Green Pine Capital Partners, QF Capital, Langke Investment, Beijing Qichen Investment Management, Glacier Capital China — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for SHANMU Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for SHANMU Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SHANMU Biotech
Developer of AI-powered micro medical robots designed for home health monitoring through digital microfluidic chipsets. The company's technologies include urine-based metabolic analysis and disease cycle management algorithms, enabling continuous health tracking and early detection of disease correlations for personalised, at-home care.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Employees
- 10
- Website
- shanmu.ltd/
- Ownership
- Privately Held (backing)
SHANMU Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SHANMU Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SHANMU Biotech in its N-PORT filings yet. We sweep new filings monthly.